These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical Translational Studies of Kisspeptin and Neurokinin B. Hunjan T; Abbara A Semin Reprod Med; 2019 May; 37(3):119-124. PubMed ID: 31869839 [TBL] [Abstract][Full Text] [Related]
3. Advances in clinical applications of kisspeptin-GnRH pathway in female reproduction. Hu KL; Chen Z; Li X; Cai E; Yang H; Chen Y; Wang C; Ju L; Deng W; Mu L Reprod Biol Endocrinol; 2022 May; 20(1):81. PubMed ID: 35606759 [TBL] [Abstract][Full Text] [Related]
4. Kisspeptin as a promising oocyte maturation trigger for in vitro fertilisation in humans. Kasum M; Franulić D; Čehić E; Orešković S; Lila A; Ejubović E Gynecol Endocrinol; 2017 Aug; 33(8):583-587. PubMed ID: 28393578 [TBL] [Abstract][Full Text] [Related]
5. Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment. Abbara A; Islam R; Clarke SA; Jeffers L; Christopoulos G; Comninos AN; Salim R; Lavery SA; Vuong TNL; Humaidan P; Kelsey TW; Trew GH; Dhillo WS Clin Endocrinol (Oxf); 2018 Jun; 88(6):920-927. PubMed ID: 29446481 [TBL] [Abstract][Full Text] [Related]
6. The direct and indirect effects of kisspeptin-54 on granulosa lutein cell function. Owens LA; Abbara A; Lerner A; O'floinn S; Christopoulos G; Khanjani S; Islam R; Hardy K; Hanyaloglu AC; Lavery SA; Dhillo WS; Franks S Hum Reprod; 2018 Feb; 33(2):292-302. PubMed ID: 29206944 [TBL] [Abstract][Full Text] [Related]
7. Ovarian hyperstimulation syndrome in the 21st century: the role of gonadotropin-releasing hormone agonist trigger and kisspeptin. Thomsen L; Humaidan P Curr Opin Obstet Gynecol; 2015 Jun; 27(3):210-4. PubMed ID: 25811256 [TBL] [Abstract][Full Text] [Related]
8. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome. Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802 [TBL] [Abstract][Full Text] [Related]
9. Use of kisspeptin to trigger oocyte maturation during Sharma B; Koysombat K; Comninos AN; Dhillo WS; Abbara A Front Endocrinol (Lausanne); 2022; 13():972137. PubMed ID: 36147569 [TBL] [Abstract][Full Text] [Related]
10. An update on the prevention of ovarian hyperstimulation syndrome. El Tokhy O; Kopeika J; El-Toukhy T Womens Health (Lond); 2016 Sep; 12(5):496-503. PubMed ID: 27543490 [TBL] [Abstract][Full Text] [Related]
11. [Potential clinical application of Kisspeptin in reproductive endocrinology]. Fu Y; Zhu Y Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(3):328-333. PubMed ID: 29039178 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy. Abbara A; Jayasena CN; Christopoulos G; Narayanaswamy S; Izzi-Engbeaya C; Nijher GM; Comninos AN; Peters D; Buckley A; Ratnasabapathy R; Prague JK; Salim R; Lavery SA; Bloom SR; Szigeti M; Ashby DA; Trew GH; Dhillo WS J Clin Endocrinol Metab; 2015 Sep; 100(9):3322-31. PubMed ID: 26192876 [TBL] [Abstract][Full Text] [Related]
13. Effects of intracerebroventricular and intravenous administration of Kisspeptin-54 and Gonadotropin-releasing hormone agonist in rats with ovarian hyperstimulation. Bilister Egilmez C; Koyu A; Azak Pazarlar B; Keselik E; Oz Oyar E; Kurus M Neuropeptides; 2022 Dec; 96():102298. PubMed ID: 36367482 [TBL] [Abstract][Full Text] [Related]
14. Potential Clinical Use of Kisspeptin. Prague JK; Dhillo WS Neuroendocrinology; 2015; 102(3):238-45. PubMed ID: 26277870 [TBL] [Abstract][Full Text] [Related]
15. The roles of kisspeptin revisited: inside and outside the hypothalamus. Uenoyama Y; Pheng V; Tsukamura H; Maeda KI J Reprod Dev; 2016 Dec; 62(6):537-545. PubMed ID: 27478063 [TBL] [Abstract][Full Text] [Related]
16. Kisspeptin signalling and its roles in humans. Tng EL Singapore Med J; 2015 Dec; 56(12):649-56. PubMed ID: 26702158 [TBL] [Abstract][Full Text] [Related]
17. Leptin actions through the nitrergic system to modulate the hypothalamic expression of the kiss1 mRNA in the female rat. Petrine JCP; Franci CR; Del Bianco-Borges B Brain Res; 2020 Feb; 1728():146574. PubMed ID: 31790683 [TBL] [Abstract][Full Text] [Related]
18. Sex steroids and the control of the Kiss1 system: developmental roles and major regulatory actions. García-Galiano D; Pinilla L; Tena-Sempere M J Neuroendocrinol; 2012 Jan; 24(1):22-33. PubMed ID: 21951227 [TBL] [Abstract][Full Text] [Related]